SOURCE-LINKED INTELLIGENCE

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

CORDIS · observation · Publication date unknown

rse remain unresolved. To meet these challenges, we have established a consortium with extensive experience in neurology and MS, genetics, virology and EBV, epidemiology, immunology, clinical trials, artificial intelligence, as well as stakeholder involvement and responsible research and innovation (RRI). By combining this expertise, the consortium takes advantage of high-quality health registries, existing research cohorts of persons with MS, and prospective randomized clinical trials of antiviral therapies targeting the EBV infection in MS. The ambitious goals are to answer the questions why only a few EBV infected persons develop MS, and define the underlying mechanism of this process, as well as clarify if targeting the EBV infection can prevent MS or improve the disease course. By answering these questions, we would meet the challenges defined in the current call: Relationship between infections and non-communicable diseases. We would contribute with knowledge to reduce disease burden by providing the health care system with new knowledge to better understand the cause of MS, i

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

7549863.25

unit

EUR